522 related articles for article (PubMed ID: 33143043)
21. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
22. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
23. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis.
Kumar S; Duan Q; Wu R; Harris EN; Su Q
Adv Drug Deliv Rev; 2021 Sep; 176():113869. PubMed ID: 34280515
[TBL] [Abstract][Full Text] [Related]
24. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
[TBL] [Abstract][Full Text] [Related]
25. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
26. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading.
Chu X; Jin Q; Chen H; Wood GC; Petrick A; Strodel W; Gabrielsen J; Benotti P; Mirshahi T; Carey DJ; Still CD; DiStefano JK; Gerhard GS
J Transl Med; 2018 Apr; 16(1):108. PubMed ID: 29690903
[TBL] [Abstract][Full Text] [Related]
27. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
[TBL] [Abstract][Full Text] [Related]
28. CXC Motif Ligand 16 Promotes Nonalcoholic Fatty Liver Disease Progression via Hepatocyte-Stellate Cell Crosstalk.
Jiang L; Yang M; Li X; Wang Y; Zhou G; Zhao J
J Clin Endocrinol Metab; 2018 Nov; 103(11):3974-3985. PubMed ID: 30053055
[TBL] [Abstract][Full Text] [Related]
29. Extracellular vesicles originating from steatotic hepatocytes promote hepatic stellate cell senescence via AKT/mTOR signaling.
Wu Z; Xia M; Wang J; Aguilar MM; Buist-Homan M; Moshage H
Cell Biochem Funct; 2024 Jun; 42(4):e4077. PubMed ID: 38881228
[TBL] [Abstract][Full Text] [Related]
30. Adipose-derived mesenchymal stem cell-secreted extracellular vesicles alleviate non-alcoholic fatty liver disease
Niu Q; Wang T; Wang Z; Wang F; Huang D; Sun H; Liu H
Adipocyte; 2022 Dec; 11(1):572-587. PubMed ID: 36093813
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive characterization of hepatocyte-derived extracellular vesicles identifies direct miRNA-based regulation of hepatic stellate cells and DAMP-based hepatic macrophage IL-1β and IL-17 upregulation in alcoholic hepatitis mice.
Eguchi A; Yan R; Pan SQ; Wu R; Kim J; Chen Y; Ansong C; Smith RD; Tempaku M; Ohno-Machado L; Takei Y; Feldstein AE; Tsukamoto H
J Mol Med (Berl); 2020 Jul; 98(7):1021-1034. PubMed ID: 32556367
[TBL] [Abstract][Full Text] [Related]
32. Extracellular Vesicles from Steatotic Hepatocytes Provoke Pro-Fibrotic Responses in Cultured Stellate Cells.
Koenen MT; Brandt EF; Kaczor DM; Caspers T; Heinzmann ACA; Fischer P; Heinrichs D; Wirtz TH; Trautwein C; Koenen RR; Berres ML
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625625
[TBL] [Abstract][Full Text] [Related]
33. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
[TBL] [Abstract][Full Text] [Related]
34. HLSC-Derived Extracellular Vesicles Attenuate Liver Fibrosis and Inflammation in a Murine Model of Non-alcoholic Steatohepatitis.
Bruno S; Pasquino C; Herrera Sanchez MB; Tapparo M; Figliolini F; Grange C; Chiabotto G; Cedrino M; Deregibus MC; Tetta C; Camussi G
Mol Ther; 2020 Feb; 28(2):479-489. PubMed ID: 31757759
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease.
Lakhani HV; Sharma D; Dodrill MW; Nawab A; Sharma N; Cottrill CL; Shapiro JI; Sodhi K
Int J Med Sci; 2018; 15(14):1591-1599. PubMed ID: 30588181
[TBL] [Abstract][Full Text] [Related]
36. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
37. GDF11 induces mild hepatic fibrosis independent of metabolic health.
Frohlich J; Kovacovicova K; Mazza T; Emma MR; Cabibi D; Foti M; Sobolewski C; Oben JA; Peyrou M; Villarroya F; Soresi M; Rezzani R; Cervello M; Bonomini F; Alisi A; Vinciguerra M
Aging (Albany NY); 2020 Oct; 12(20):20024-20046. PubMed ID: 33126224
[TBL] [Abstract][Full Text] [Related]
38. Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease.
Han M; Piorońska W; Wang S; Nwosu ZC; Sticht C; Wang S; Gao Y; Ebert MP; Dooley S; Meyer C
Cell Death Dis; 2020 Feb; 11(2):104. PubMed ID: 32029710
[TBL] [Abstract][Full Text] [Related]
39. Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis.
Povero D; Pinatel EM; Leszczynska A; Goyal NP; Nishio T; Kim J; Kneiber D; de Araujo Horcel L; Eguchi A; Ordonez PM; Kisseleva T; Feldstein AE
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184999
[TBL] [Abstract][Full Text] [Related]
40. A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease.
Chen Z; Yu R; Xiong Y; Du F; Zhu S
Lipids Health Dis; 2017 Oct; 16(1):203. PubMed ID: 29037210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
